Hims & Hers Health, Inc. (HIMS) Misses Q4 EPS by 8c

Hims & Hers Health, Inc. (NYSE: HIMS) reported Q4 EPS of ($0.15), $0.08 worse than the analyst estimate of ($0.07). Revenue for the quarter came in at $84.7 million versus the consensus estimate of $76.79 million.

GUIDANCE:

Hims & Hers Health, Inc. sees FY2022 revenue of $365-380 million, versus the consensus of $350 million.

For earnings history and earnings-related data on Hims & Hers Health, Inc. (HIMS) click here.

You May Also Be Interested In

• Hims and Hers (HIMS) PT Raised to $42 at Needham
• Star Equity Holdings (STRR) Misses Q2 EPS by 8c
• Silexion Therapeutics (SLXN) Tops Q2 EPS by 793c